Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5-phosphate
The capsule contains artificially synthesized GLP1 receptor agonists (such as oral formulations of semaglutide and liraglutide), which activate the systemic GLP1 receptors by simulating the action of natural GLP1, achieving blood glucose control, appetite suppression, and energy consumption optimization
Sabrina Haque U, Kohut M, Yokota T
Any change in diabetes medication should be individualised, taking into account the patient's preferences, comorbidities, and treatment objectives
doi: 10.1016/j.tcb.2015.10.014 84 KangRTangD
Depressive Rumination, the Default-Mode Network, and the Dark Matter of Clinical Neuroscience